ArticleFrontiers in oncology2026

Impact of post-resistance molecular retesting strategies on treatment timeliness and clinical outcomes in EGFR-mutant advanced NSCLC: a real-world study.

Wenting Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.